NO975583D0 - Fremstilling av et acylert proteinpulver - Google Patents
Fremstilling av et acylert proteinpulverInfo
- Publication number
- NO975583D0 NO975583D0 NO975583A NO975583A NO975583D0 NO 975583 D0 NO975583 D0 NO 975583D0 NO 975583 A NO975583 A NO 975583A NO 975583 A NO975583 A NO 975583A NO 975583 D0 NO975583 D0 NO 975583D0
- Authority
- NO
- Norway
- Prior art keywords
- protein
- preparation
- protein powder
- acylated protein
- acylated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,220 US5700904A (en) | 1995-06-07 | 1995-06-07 | Preparation of an acylated protein powder |
PCT/US1996/007963 WO1996040730A1 (en) | 1995-06-07 | 1996-06-04 | Preparation of an acylated protein powder |
Publications (2)
Publication Number | Publication Date |
---|---|
NO975583L NO975583L (no) | 1997-12-03 |
NO975583D0 true NO975583D0 (no) | 1997-12-03 |
Family
ID=23923252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO975583A NO975583D0 (no) | 1995-06-07 | 1997-12-03 | Fremstilling av et acylert proteinpulver |
Country Status (21)
Country | Link |
---|---|
US (1) | US5700904A (no) |
EP (1) | EP0747391B1 (no) |
JP (1) | JP3844504B2 (no) |
KR (1) | KR19990022590A (no) |
CN (1) | CN1192218A (no) |
AT (1) | ATE263185T1 (no) |
AU (1) | AU703032B2 (no) |
BR (1) | BR9608729A (no) |
CA (1) | CA2223389A1 (no) |
CZ (1) | CZ388197A3 (no) |
DE (1) | DE69631996T2 (no) |
DK (1) | DK0747391T3 (no) |
EA (1) | EA199800042A1 (no) |
ES (1) | ES2216039T3 (no) |
HU (1) | HUP9900877A3 (no) |
IL (1) | IL122460A0 (no) |
NO (1) | NO975583D0 (no) |
NZ (1) | NZ309371A (no) |
PL (1) | PL323994A1 (no) |
TR (1) | TR199701528T1 (no) |
WO (1) | WO1996040730A1 (no) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9316895D0 (en) | 1993-08-13 | 1993-09-29 | Guy S And St Thomas Hospitals | Hepatoselective insulin analogues |
US5986050A (en) * | 1996-12-26 | 1999-11-16 | Poly-Med, Inc. | Peracylated proteins and synthetic polypeptides and process for making the same |
US5898067A (en) * | 1997-02-07 | 1999-04-27 | Novo Nordisk A/S | Crystallization of proteins |
JP3343129B2 (ja) * | 1997-02-07 | 2002-11-11 | ノボ ノルディスク アクティーゼルスカブ | タンパク質の結晶化 |
EP1627642A3 (en) * | 1997-03-20 | 2006-04-19 | Novo Nordisk A/S | Zinc free insulin crystals for use in pulmonary compositions |
US6310038B1 (en) * | 1997-03-20 | 2001-10-30 | Novo Nordisk A/S | Pulmonary insulin crystals |
US5898028A (en) * | 1997-03-20 | 1999-04-27 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
PE123799A1 (es) * | 1997-10-24 | 1999-12-13 | Lilly Co Eli | Composiciones insolubles de insulina |
ZA989644B (en) * | 1997-10-24 | 2000-04-25 | Lilly Co Eli | Insoluble insulen compositions. |
ZA989744B (en) * | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
EP1396272A1 (en) * | 1997-12-23 | 2004-03-10 | Eli Lilly & Company | Insoluble Insulin Compositions for Controlling Blood Glucose |
US6531448B1 (en) * | 1997-12-23 | 2003-03-11 | Eli Lilly And Company | Insoluble compositions for controlling blood glucose |
US6855260B1 (en) * | 1999-06-07 | 2005-02-15 | Roe-Hoan Yoon | Methods of enhancing fine particle dewatering |
US6526675B1 (en) * | 1999-06-07 | 2003-03-04 | Roe-Hoan Yoon | Methods of using natural products as dewatering aids for fine particles |
US7169889B1 (en) | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
US6799682B1 (en) | 2000-05-16 | 2004-10-05 | Roe-Hoan Yoon | Method of increasing flotation rate |
US6663602B2 (en) | 2000-06-16 | 2003-12-16 | Novo Nordisk A/S | Injection device |
US6835802B2 (en) * | 2001-06-04 | 2004-12-28 | Nobex Corporation | Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties |
US6828305B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6858580B2 (en) * | 2001-06-04 | 2005-02-22 | Nobex Corporation | Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US7713932B2 (en) | 2001-06-04 | 2010-05-11 | Biocon Limited | Calcitonin drug-oligomer conjugates, and uses thereof |
US6713452B2 (en) * | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US7312192B2 (en) | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7166571B2 (en) | 2001-09-07 | 2007-01-23 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US6770625B2 (en) | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
US6913903B2 (en) | 2001-09-07 | 2005-07-05 | Nobex Corporation | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
AU2003226603A1 (en) * | 2002-04-19 | 2003-11-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders |
EP1562975A2 (en) * | 2002-10-25 | 2005-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments |
CA2523267C (en) | 2003-04-23 | 2013-09-03 | Biovalve Technologies, Inc. | Hydraulically actuated pump for long duration medicament administration |
US7122542B2 (en) | 2003-07-30 | 2006-10-17 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
UA103758C2 (ru) | 2004-07-19 | 2013-11-25 | Биокон Лимитед | Конъюгаты олигомеров инсулина, их композиции и применение |
USRE46363E1 (en) | 2004-10-21 | 2017-04-11 | Novo Nordisk A/S | Dial-down mechanism for wind-up pen |
JP4022595B2 (ja) * | 2004-10-26 | 2007-12-19 | コニカミノルタオプト株式会社 | 撮影装置 |
US8007754B2 (en) | 2005-02-04 | 2011-08-30 | Mineral And Coal Technologies, Inc. | Separation of diamond from gangue minerals |
US20090043264A1 (en) | 2005-04-24 | 2009-02-12 | Novo Nordisk A/S | Injection Device |
US20070203161A1 (en) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
NZ563454A (en) | 2005-06-08 | 2011-03-31 | Rigel Pharmaceuticals Inc | 2,4-diaminopyrimidine derivatives for inhibition of the JAK pathway |
US7741281B2 (en) * | 2005-11-03 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8962643B2 (en) * | 2006-02-24 | 2015-02-24 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
JP5062768B2 (ja) | 2006-03-10 | 2012-10-31 | ノボ・ノルデイスク・エー/エス | 注射装置および該装置のカートリッジを交換する方法 |
JP5183499B2 (ja) | 2006-03-10 | 2013-04-17 | ノボ・ノルデイスク・エー/エス | 注射装置 |
WO2007115039A2 (en) | 2006-03-30 | 2007-10-11 | Valeritas, Llc | Multi-cartridge fluid delivery device |
EP2004671B1 (en) * | 2006-03-30 | 2015-12-09 | Novo Nordisk A/S | Two-phase precipitation of proteins |
US7714025B2 (en) * | 2006-05-10 | 2010-05-11 | Arizona Biomedical Research Commission | Modified chalcone compounds as antimitotic agents |
DE602007004972D1 (de) | 2006-05-16 | 2010-04-08 | Novo Nordisk As | Getriebemechanismus für ein injektionsgerät |
AU2007253481B2 (en) | 2006-05-18 | 2013-01-17 | Novo Nordisk A/S | An injection device with mode locking means |
EP2125081B1 (en) | 2007-03-23 | 2017-12-20 | Novo Nordisk A/S | An injection device comprising a locking nut |
BRPI0818004B8 (pt) | 2007-10-16 | 2021-05-25 | Biocon Ltd | composição farmacêutica sólida administrável por via oral e o processo da mesma. |
PE20150621A1 (es) | 2009-01-23 | 2015-05-07 | Rigel Pharmaceuticals Inc | Derivados de 2,4-diamino-pirimidina n2, n4-disustituidos como inhibidores de jak3 |
WO2011064316A2 (en) | 2009-11-25 | 2011-06-03 | Paolo Botti | Mucosal delivery of peptides |
ES2880622T3 (es) | 2010-07-28 | 2021-11-25 | Rigel Pharmaceuticals Inc | Composiciones y procedimientos para la inhibición de la ruta de JAK |
CN103998077B (zh) | 2011-12-29 | 2017-05-31 | 诺沃—诺迪斯克有限公司 | 具有向上拨动/向下拨动定量机构的基于扭力弹簧的卷紧自动注射器笔 |
WO2013142038A2 (en) | 2012-03-23 | 2013-09-26 | Oxigene, Inc. | Compositions and methods for inhibition of cathepsins |
US11206846B2 (en) * | 2017-05-02 | 2021-12-28 | Leprino Foods Company | High purity alpha lactalbumin and methods of making |
EP3688024A4 (en) | 2017-09-26 | 2021-07-14 | Biocon Biologics India Limited | BUILT-IN AUTOMATED FILTRATION FOR SEPARATION, WASHING AND DRYING OF PEPTIDE CRYSTALS |
WO2020092845A1 (en) | 2018-11-01 | 2020-05-07 | Rigel Pharmaceuticals, Inc. | Method and composition embodiments for treating acute myeloid leukemia |
WO2020243612A1 (en) | 2019-05-29 | 2020-12-03 | Rigel Pharmaceuticals, Inc. | Method of preventing and treating thrombosis |
JP2022543843A (ja) | 2019-08-08 | 2022-10-14 | ライジェル ファーマシューティカルズ, インコーポレイテッド | サイトカイン放出症候群を治療するための化合物及び方法 |
EP4013420B1 (en) | 2019-08-14 | 2023-11-01 | Rigel Pharmaceuticals, Inc. | Method of blocking or ameliorating cytokine release syndrome |
TW202346291A (zh) | 2022-03-23 | 2023-12-01 | 美商雷傑製藥公司 | 作為irak抑制劑的嘧啶—2—基—吡唑化合物 |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1468831A (fr) * | 1965-10-05 | 1967-02-10 | Roussel Uclaf | Procédé de préparation de nouveaux composés polypeptidiques et produits en résultant |
DE1902865A1 (de) * | 1968-02-01 | 1969-09-11 | American Home Prod | Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen |
US3591574A (en) * | 1968-05-29 | 1971-07-06 | American Home Prod | Tri-n-phenylglycyl derivatives of insulin |
US3528960A (en) * | 1968-10-07 | 1970-09-15 | Lilly Co Eli | N-carboxyaroyl insulins |
US3823125A (en) * | 1969-10-14 | 1974-07-09 | American Home Prod | N-aminoacyl-substituted insulins |
US3752798A (en) * | 1969-12-02 | 1973-08-14 | G Amird | Tris-na1,nb1,nepsilonb29 - (3-x-3-oxo - 1-y-prop-1-en-1-yl)(ndelta-(4-z-6-r-pyrimidin - 2 - yl) ornithine b22)-insulins and their preparation |
US3950517A (en) * | 1970-05-08 | 1976-04-13 | National Research Development Corporation | Insulin derivatives |
US3869437A (en) * | 1970-05-08 | 1975-03-04 | Nat Res Dev | Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin |
GB1381274A (en) * | 1971-01-28 | 1975-01-22 | Nat Res Dev | Insulin derivatives |
GB1381273A (en) * | 1971-01-28 | 1975-01-22 | Nat Res Dev | Insulin derivatives |
US3864325A (en) * | 1971-11-18 | 1975-02-04 | Nat Res Dev | (N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives |
BE791949A (fr) * | 1971-11-27 | 1973-05-28 | Schering Ag | Derives d'insuline, leur preparation et leur utilisation |
US3843815A (en) * | 1972-02-10 | 1974-10-22 | Gen Foods Corp | Inhibiting gel formation in meat-in-gravy products |
US3755569A (en) * | 1972-07-25 | 1973-08-28 | American Home Prod | Acyl substituted insulins |
DE2252157C3 (de) * | 1972-10-25 | 1976-03-18 | Hoechst Ag | Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten |
NL7314766A (no) * | 1972-10-31 | 1974-05-02 | ||
DE2253327A1 (de) * | 1972-10-31 | 1974-05-09 | Hoechst Ag | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten |
DE2428412A1 (de) * | 1974-06-12 | 1976-01-15 | Hoechst Ag | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten |
DE2439296A1 (de) * | 1974-08-16 | 1976-02-26 | Hoechst Ag | Verfahren zur herstellung von insulin, insulin-analogen und -derivaten |
GB1492997A (en) * | 1976-07-21 | 1977-11-23 | Nat Res Dev | Insulin derivatives |
EP0014815A3 (de) * | 1978-12-20 | 1980-10-29 | Ciba-Geigy Ag | Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen |
US4486458A (en) * | 1982-09-07 | 1984-12-04 | A. E. Staley Manufacturing Company | Non-gelling corn steep liquor |
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
JPS6255096A (ja) * | 1986-06-12 | 1987-03-10 | Nippon Shinyaku Co Ltd | 新規な脂肪酸アシル化合物 |
JPH01254699A (ja) * | 1988-04-05 | 1989-10-11 | Kodama Kk | インスリン誘導体及びその用途 |
NZ232375A (en) * | 1989-02-09 | 1992-04-28 | Lilly Co Eli | Insulin analogues modified at b29 |
AU8091091A (en) * | 1990-07-26 | 1992-02-18 | University Of Iowa Research Foundation, The | Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule |
US5304473A (en) * | 1991-06-11 | 1994-04-19 | Eli Lilly And Company | A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
AU5574094A (en) * | 1992-11-30 | 1994-06-22 | Biosignal Kutato-Fejleszto Kft. | Polyunsaturated fatty acyl-peptide composition |
-
1995
- 1995-06-07 US US08/484,220 patent/US5700904A/en not_active Expired - Fee Related
-
1996
- 1996-05-31 DK DK96303974T patent/DK0747391T3/da active
- 1996-05-31 EP EP96303974A patent/EP0747391B1/en not_active Expired - Lifetime
- 1996-05-31 DE DE69631996T patent/DE69631996T2/de not_active Expired - Fee Related
- 1996-05-31 AT AT96303974T patent/ATE263185T1/de not_active IP Right Cessation
- 1996-05-31 ES ES96303974T patent/ES2216039T3/es not_active Expired - Lifetime
- 1996-06-04 HU HU9900877A patent/HUP9900877A3/hu unknown
- 1996-06-04 WO PCT/US1996/007963 patent/WO1996040730A1/en not_active Application Discontinuation
- 1996-06-04 CN CN96195951A patent/CN1192218A/zh active Pending
- 1996-06-04 IL IL12246096A patent/IL122460A0/xx unknown
- 1996-06-04 CZ CZ973881A patent/CZ388197A3/cs unknown
- 1996-06-04 NZ NZ309371A patent/NZ309371A/en unknown
- 1996-06-04 BR BR9608729A patent/BR9608729A/pt not_active Application Discontinuation
- 1996-06-04 JP JP50083297A patent/JP3844504B2/ja not_active Expired - Fee Related
- 1996-06-04 PL PL96323994A patent/PL323994A1/xx unknown
- 1996-06-04 CA CA002223389A patent/CA2223389A1/en not_active Abandoned
- 1996-06-04 AU AU59513/96A patent/AU703032B2/en not_active Ceased
- 1996-06-04 EA EA199800042A patent/EA199800042A1/ru unknown
- 1996-06-04 TR TR97/01528T patent/TR199701528T1/xx unknown
- 1996-06-04 KR KR1019970709071A patent/KR19990022590A/ko not_active Application Discontinuation
-
1997
- 1997-12-03 NO NO975583A patent/NO975583D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO975583L (no) | 1997-12-03 |
AU703032B2 (en) | 1999-03-11 |
JP3844504B2 (ja) | 2006-11-15 |
US5700904A (en) | 1997-12-23 |
JPH11506738A (ja) | 1999-06-15 |
CA2223389A1 (en) | 1996-12-19 |
IL122460A0 (en) | 1998-06-15 |
KR19990022590A (ko) | 1999-03-25 |
DK0747391T3 (da) | 2004-07-19 |
ES2216039T3 (es) | 2004-10-16 |
DE69631996T2 (de) | 2005-01-27 |
MX9709657A (es) | 1998-07-31 |
CZ388197A3 (cs) | 1998-05-13 |
EA199800042A1 (ru) | 1998-08-27 |
BR9608729A (pt) | 1999-06-29 |
CN1192218A (zh) | 1998-09-02 |
NZ309371A (en) | 1999-09-29 |
AU5951396A (en) | 1996-12-30 |
EP0747391A3 (en) | 1997-05-21 |
ATE263185T1 (de) | 2004-04-15 |
DE69631996D1 (de) | 2004-05-06 |
WO1996040730A1 (en) | 1996-12-19 |
HUP9900877A2 (hu) | 1999-07-28 |
HUP9900877A3 (en) | 1999-11-29 |
TR199701528T1 (xx) | 1998-03-21 |
PL323994A1 (en) | 1998-04-27 |
EP0747391A2 (en) | 1996-12-11 |
EP0747391B1 (en) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO975583D0 (no) | Fremstilling av et acylert proteinpulver | |
TW372945B (en) | Method for preparing hydrophobic clay method to make hydrophobic clay | |
IN181859B (no) | ||
ATE195076T1 (de) | Verfahren zur isolierung von haemopnilus influenzae protein-e | |
MY126727A (en) | Process for isolating a protein composition from a muscle source and protein composition | |
EA199900980A1 (ru) | Улучшенные способы приготовления активированного белка с | |
IE892974L (en) | Hydrophobic protein microparticles and preparation thereof | |
WO1990003123A3 (en) | Hydrophobic protein microparticles and preparation thereof | |
DE59107901D1 (de) | Verfahren zur herstellung gereinigter glycolipide durch membrantrennverfahren | |
MY127603A (en) | Method to remove citrate and aluminum from proteins | |
CS21192A3 (en) | Complex containing precipitation factor ix | |
DE69403210D1 (de) | Verfahren zur herstellung von n-acetylneuraminsäure | |
FI950094A0 (fi) | Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi | |
AU5685586A (en) | Method of producing low-fat whey proteins | |
SE8600987L (sv) | Forfarande for framstellning av ett protein- koncentrat ur helblod | |
NZ235297A (en) | Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution | |
AU5283899A (en) | Method for precipitating 2-chloronicotinic acid from aqueous solutions | |
DE3270177D1 (en) | Process for purifying elastase | |
ZA963713B (en) | Erythropoletin free of animal proteins as well as processes for production and use. | |
GB8906796D0 (en) | Method of enhancing neutralising antibody activity in human or animal sera or in other body secretions | |
SU1577372A1 (ru) | Способ получения пятиокиси ванадия из растворов | |
RU95113938A (ru) | Способ моделирования аллергического стеноза гортани | |
KR920019809A (ko) | 대두올리고당의 제조 방법 | |
PL176271B1 (pl) | Sposób otrzymywania enzymatycznego hydrolizatu kazeiny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |